InsiderClue
Stocks · Health care · Pharmaceutical Preparations

Cadrenal Therapeutics, Inc.

CVKD Clue Score29
United States Fiscal year ends December CIK 0001937993
$0.91 -2.10% Close, 9 Oct 2026
Alert on the numbers Alert on insider trades
Price $0.91 +46.79% Close, 9 Oct 2026

Closing prices at the end of each trading day, from 20 Jan 2023. Not a live quote. Adjusted for share splits, so the line has no step at a split; dividends are not added back.

Revenue and profit

What the business sells, and what is left of it. Point at a year for the detail.
Operating incomeNet income
Fiscal year 2022Operating income−2.7Net income−6.7EPS, diluted−0.85Fiscal year 2023Operating income−7.6Net income−8.4EPS, diluted−9.29Fiscal year 2024Operating income−11.0Net income−10.7EPS, diluted−8.73Fiscal year 2025Operating income−13.5Net income−13.2EPS, diluted−6.64
FY2022FY2023FY2024FY2025
Operating income −2.7 −7.6 −11.0 −13.5
Net income −6.7 −8.4 −10.7 −13.2
Growth
EPS, diluted −0.85 −9.29 −8.73 −6.64

Cash flow

The cash the business makes, what it reinvests, and what it hands back. Point at a year for the detail.
Operating cash flowCapital expenditureFree cash flow
Fiscal year 2022Operating cash flow−1.2Capital expenditure−0.0Free cash flow−1.2Fiscal year 2023Operating cash flow−3.5Capital expenditure−0.0Free cash flow−3.5Fiscal year 2024Operating cash flow−7.4Capital expenditure−0.0Free cash flow−7.4Fiscal year 2025Operating cash flow−12.6Capital expenditure−0.0Free cash flow−12.6
FY2022FY2023FY2024FY2025
Operating cash flow −1.2 −3.5 −7.4 −12.6
Capital expenditure −0.0 −0.0 −0.0 −0.0
Free cash flow −1.2 −3.5 −7.4 −12.6
Growth

Balance sheet

What it holds against what it owes, at each year end. Point at a year for the detail.
Cash
Fiscal year 2022Cash0.0Shareholders’ equity−5.6Fiscal year 2023Cash8.4Shareholders’ equity7.7Fiscal year 2024Cash10.0Shareholders’ equity7.4Fiscal year 2025Cash4.0Shareholders’ equity2.7
FY2022FY2023FY2024FY2025
Cash 0.0 8.4 10.0 4.0
Shareholders’ equity −5.6 7.7 7.4 2.7

In millions of USD, except per-share figures and ratios. Fiscal years, as last filed with the SEC.

Financial statements FY2025 · 10-K

Ratios

Percentages worked out from the filed figures; debt to equity in times. Fiscal years ending December, each column as last filed with the SEC.
Click a line to chart it
Fiscal year FY2022 31 Dec 2022 FY2023 31 Dec 2023 FY2024 31 Dec 2024 FY2025 31 Dec 2025
Returns
n/a −108.6% −143.2% −483.3%
−862.8% −98.1% −105.2% −305.9%
Balance and payout
813.4% 9.7% 26.5% 36.7%